Sandoz Recalls Aprepitant Capsules and Lidocaine and Prilocaine Cream Prescription Drugs Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning
The recalled prescription drugs and products that contain lidocaine must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.
Related posts:
Goumi Recalls Children’s Robes Due to Violation of Federal Flammability Standards and Burn Hazard (R...April 12, 2023
Lucky Global Recalls Lelinta Multi-Purpose Kids Helmets Due to Risk of Head Injury; Sold Exclusively...April 19, 2023
JBM International Electric Recalls Adult Bike Helmets Due to Risk of Head Injury; Sold Exclusively o...March 29, 2023
Views: 214